Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...

The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health ...

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...

A new study of more than 1.2 million people found no link between aluminum in childhood vaccines and long-term health ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

Researchers say findings indicate the drugs offer neuroprotective benefits beyond glucose control and weight loss. Experts ...

Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study. People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...